Biotage AB Statistics

Total Valuation

Biotage AB has a market cap or net worth of SEK 9.63 billion. The enterprise value is 9.45 billion.

Market Cap	9.63B
Enterprise Value	9.45B

Important Dates

The last earnings date was Wednesday, February 19, 2025.

Earnings Date	Feb 19, 2025
Ex-Dividend Date	Apr 26, 2024

Share Statistics

Biotage AB has 80.05 million shares outstanding. The number of shares has increased by 8.25% in one year.

Current Share Class	n/a
Shares Outstanding	80.05M
Shares Change (YoY)	+8.25%
Shares Change (QoQ)	+0.07%
Owned by Insiders (%)	0.66%
Owned by Institutions (%)	61.35%
Float	65.93M

Valuation Ratios

The trailing PE ratio is 33.90 and the forward PE ratio is 35.15. Biotage AB's PEG ratio is 3.32.

PE Ratio	33.90
Forward PE	35.15
PS Ratio	4.68
PB Ratio	2.34
P/TBV Ratio	9.62
P/FCF Ratio	29.72
P/OCF Ratio	n/a
PEG Ratio	3.32

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.63, with an EV/FCF ratio of 29.15.

EV / Earnings	33.26
EV / Sales	4.59
EV / EBITDA	16.63
EV / EBIT	24.66
EV / FCF	29.15

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.06.

Current Ratio	2.33
Quick Ratio	1.49
Debt / Equity	0.06
Debt / EBITDA	0.44
Debt / FCF	0.77
Interest Coverage	6.96

Financial Efficiency

Return on equity (ROE) is 7.31% and return on invested capital (ROIC) is 5.78%.

Return on Equity (ROE)	7.31%
Return on Assets (ROA)	4.77%
Return on Invested Capital (ROIC)	5.78%
Return on Capital Employed (ROCE)	8.47%
Revenue Per Employee	3.05M
Profits Per Employee	421,991
Employee Count	674
Asset Turnover	0.41
Inventory Turnover	1.71

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -32.42% in the last 52 weeks. The beta is 0.84, so Biotage AB's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-32.42%
50-Day Moving Average	145.67
200-Day Moving Average	168.55
Relative Strength Index (RSI)	36.15
Average Volume (20 Days)	320,839

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biotage AB had revenue of SEK 2.06 billion and earned 284.00 million in profits. Earnings per share was 3.55.

Revenue	2.06B
Gross Profit	1.29B
Operating Income	383.00M
Pretax Income	328.00M
Net Income	284.00M
EBITDA	568.00M
EBIT	383.00M
Earnings Per Share (EPS)	3.55

Full Income Statement

Balance Sheet

The company has 434.00 million in cash and 250.00 million in debt, giving a net cash position of 184.00 million or 2.30 per share.

Cash & Cash Equivalents	434.00M
Total Debt	250.00M
Net Cash	184.00M
Net Cash Per Share	2.30
Equity (Book Value)	4.11B
Book Value Per Share	51.38
Working Capital	776.00M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 413.00 million and capital expenditures -89.00 million, giving a free cash flow of 324.00 million.

Operating Cash Flow	413.00M
Capital Expenditures	-89.00M
Free Cash Flow	324.00M
FCF Per Share	4.05

Full Cash Flow Statement

Margins

Gross margin is 62.69%, with operating and profit margins of 18.63% and 13.81%.

Gross Margin	62.69%
Operating Margin	18.63%
Pretax Margin	15.95%
Profit Margin	13.81%
EBITDA Margin	27.63%
EBIT Margin	18.63%
FCF Margin	15.76%

Dividends & Yields

This stock pays an annual dividend of 1.65, which amounts to a dividend yield of 1.40%.

Dividend Per Share	1.65
Dividend Yield	1.40%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	45.07%
Buyback Yield	-8.25%
Shareholder Yield	-6.85%
Earnings Yield	2.95%
FCF Yield	3.36%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Biotage AB has an Altman Z-Score of 9.5.

Altman Z-Score	9.5
Piotroski F-Score	n/a